Australia markets closed

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2900+0.0600 (+4.88%)
At close: 04:00PM EDT
1.2799 -0.01 (-0.78%)
After hours: 07:43PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.16-0.04-0.45-0.45
Low estimate-0.22-0.2-0.75-0.64
High estimate-0.130.36-0.08-0.07
Year ago EPS-0.16-0.33-0.57-0.45
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6667
Avg. EstimateN/A510k14.19M59.15M
Low estimateN/AN/A1.38M4.27M
High estimateN/A1.99M54.63M163.1M
Year ago salesN/AN/AN/A14.19M
Sales growth (year/est)N/AN/AN/A316.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.22-0.16-0.15-0.15
Actual EPS-0.16-0.33-0.01-0.1
Difference0.06-0.170.140.05
Surprise %27.30%-106.20%93.30%33.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.16-0.04-0.45-0.45
7 days ago-0.16-0.04-0.45-0.45
30 days ago-0.15-0.01-0.45-0.44
60 days ago-0.16-0.04-0.45-0.34
90 days ago-0.16-0.04-0.45-0.34
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A2N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXFORIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.87.90%N/AN/AN/A
Current year21.10%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A